Showing results (141-150 of 182) with videos related to
Sort By:
Pageof 19
American Journal of Clinical Oncology|June 7, 2007
Dosimetry of an extracapsular anulus following permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.American Journal of Clinical Oncology|December 17, 2009
Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapyJesse N Aronowitz, Jeff M Michalski, Gregory S Merrick, et al.Brachytherapy|February 8, 2007
American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103Mark J Rivard, Wayne M Butler, Phillip M Devlin, et al.Urologic Nursing|August 31, 2006
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part III--A rapid review of FDA-approved cholesterol-lowering agentsMark A Moyad, Gregory S MerrickUrologic Nursing|May 18, 2006
Cholesterol, cholesterol lowering agents/statins, and urologic disease: part I - knowing your numbersMark A Moyad, Gregory S MerrickUrologic Nursing|May 15, 2007
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?Mark A Moyad, Gregory S MerrickUrologic Nursing|May 15, 2007
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part VI--The recent rise and fall of the HDL-boosting drug torceptrapibMark A Moyad, Gregory S MerrickUrologic Oncology|May 12, 2005
Statins and cholesterol lowering after a cancer diagnosis: why not?Mark A Moyad, Gregory S MerrickOncology (Williston Park, N.Y.)|October 10, 2006
Treatment of prostate cancer in obese patientsHiroki Mitsuyama, Kent E Wallner, Gregory S MerrickBrachytherapy|December 14, 2005
Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysisGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.Pageof 19